News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
297,094 Results
Type
Article (9993)
Company Profile (28)
Press Release (287073)
Multimedia
Podcasts (11)
Webinars (8)
Section
Business (105813)
Career Advice (774)
Deals (19402)
Drug Delivery (25)
Drug Development (27863)
Employer Resources (53)
FDA (4873)
Job Trends (5373)
News (158021)
Policy (10706)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (2)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
2026 Genetown Elite (1)
Academia (517)
Accelerated approval (2)
Adcomms (4)
Allergies (19)
Alliances (18944)
ALS (33)
Alzheimer's disease (405)
Antibody-drug conjugate (ADC) (33)
Approvals (4889)
Artificial intelligence (72)
Autoimmune disease (10)
Automation (6)
Bankruptcy (147)
Best Places to Work (4074)
BIOSECURE Act (2)
Biosimilars (19)
Biotechnology (29)
Bladder cancer (12)
Brain cancer (11)
Breast cancer (96)
Cancer (725)
Cardiovascular disease (37)
Career advice (667)
Career pathing (6)
CAR-T (46)
Cell therapy (162)
Cervical cancer (4)
Clinical research (23058)
Collaboration (283)
Compensation (234)
Complete response letters (5)
COVID-19 (603)
CRISPR (10)
C-suite (154)
Cystic fibrosis (34)
Data (808)
Denatured (3)
Depression (11)
Diabetes (93)
Diagnostics (2669)
Digital health (5)
Diversity, equity & inclusion (17)
Drug discovery (39)
Drug pricing (17)
Drug shortages (6)
Duchenne muscular dystrophy (35)
Earnings (50682)
Editorial (13)
Employer branding (9)
Employer resources (53)
Events (48584)
Executive appointments (489)
FDA (5283)
Featured Employer (8)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (308)
Gene editing (29)
Generative AI (3)
Gene therapy (93)
GLP-1 (214)
Government (907)
Grass and pollen (1)
Guidances (25)
Healthcare (7386)
Huntington's disease (4)
IgA nephropathy (7)
Immunology and inflammation (33)
Indications (8)
Infectious disease (643)
Inflammatory bowel disease (61)
Inflation Reduction Act (2)
Influenza (16)
Intellectual property (37)
Interviews (95)
IPO (9756)
IRA (9)
Job creations (1411)
Job search strategy (602)
Kidney cancer (8)
Labor market (10)
Layoffs (148)
Leadership (7)
Legal (3109)
Liver cancer (23)
Lung cancer (83)
Lymphoma (45)
Management (16)
Manufacturing (105)
MASH (37)
Medical device (5439)
Medtech (5442)
Mergers & acquisitions (9995)
Metabolic disorders (227)
Multiple sclerosis (18)
NASH (6)
Neurodegenerative disease (26)
Neuropsychiatric disorders (4)
Neuroscience (574)
NextGen: Class of 2025 (2305)
Non-profit (1091)
Northern California (1307)
Now hiring (6)
Obesity (104)
Opinion (69)
Ovarian cancer (30)
Pain (29)
Pancreatic cancer (27)
Parkinson's disease (50)
Partnered (5)
Patents (64)
Patient recruitment (41)
Peanut (7)
People (33521)
Pharmaceutical (12)
Pharmacy benefit managers (5)
Phase I (7165)
Phase II (10452)
Phase III (7725)
Pipeline (688)
Policy (31)
Postmarket research (762)
Preclinical (2810)
Press Release (68)
Prostate cancer (43)
Psychedelics (8)
Radiopharmaceuticals (150)
Rare diseases (120)
Real estate (2294)
Recruiting (21)
Regulatory (7339)
Reports (21)
Research institute (537)
Resumes & cover letters (108)
Rett syndrome (3)
RSV (4)
Schizophrenia (35)
Series A (58)
Series B (33)
Service/supplier (1)
Sickle cell disease (21)
Southern California (1072)
Special edition (3)
Spinal muscular atrophy (41)
Sponsored (10)
Startups (1420)
State (1)
Stomach cancer (1)
Supply chain (26)
Tariffs (6)
The Weekly (8)
United States (10243)
Vaccines (130)
Venture capitalists (10)
Weight loss (55)
Women's health (8)
Worklife (2)
Date
Today (73)
Last 7 days (251)
Last 30 days (1106)
Last 365 days (14932)
2025 (4412)
2024 (16334)
2023 (18933)
2022 (25801)
2021 (27098)
2020 (24535)
2019 (17904)
2018 (13664)
2017 (13535)
2016 (12442)
2015 (15595)
2014 (12226)
2013 (9797)
2012 (10527)
2011 (11070)
2010 (10626)
Location
Africa (275)
Alabama (18)
Alaska (4)
Arizona (79)
Arkansas (5)
Asia (16913)
Australia (2493)
California (2871)
Canada (989)
China (135)
Colorado (129)
Connecticut (128)
Delaware (38)
Europe (35417)
Florida (405)
Georgia (67)
Idaho (24)
Illinois (174)
India (11)
Indiana (139)
Iowa (4)
Japan (86)
Kansas (30)
Kentucky (12)
Louisiana (5)
Maine (43)
Maryland (349)
Massachusetts (2070)
Michigan (99)
Minnesota (177)
Mississippi (1)
Missouri (28)
Montana (26)
Nebraska (13)
Nevada (40)
New Hampshire (22)
New Jersey (909)
New Mexico (11)
New York (722)
North Carolina (488)
North Dakota (3)
Northern California (1307)
Ohio (88)
Oklahoma (8)
Oregon (7)
Pennsylvania (539)
Puerto Rico (6)
Rhode Island (16)
South America (411)
South Carolina (6)
Southern California (1072)
Tennessee (46)
Texas (364)
Utah (87)
Virginia (48)
Washington D.C. (16)
Washington State (210)
West Virginia (2)
Wisconsin (24)
297,094 Results for "integra lifesciences holdings corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025
April 18, 2025
·
1 min read
Press Releases
Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
March 14, 2025
·
1 min read
Business
Integra LifeSciences Reports First Quarter 2024 Financial Results
Integra LifeSciences Holdings Corporation, a leading global medical technology company, reported financial results for the first quarter ending March 31, 2024.
May 6, 2024
·
22 min read
Deals
Integra LifeSciences Completes the Acquisition of Acclarent, Inc.
Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has successfully completed its acquisition of Acclarent, Inc., a pioneer in ear, nose and throat (ENT) surgical interventions.
April 1, 2024
·
5 min read
Press Releases
Integra LifeSciences to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on February 25, 2025
February 4, 2025
·
1 min read
Press Releases
Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 Financial Guidance
February 25, 2025
·
26 min read
Business
Integra LifeSciences Announces Leadership Transition Plan
Integra LifeSciences Holdings Corporation, a leading global medical technology company, announced that Jan De Witte has informed the Board of Directors of his intention to retire from his position as president and chief executive officer of Integra following the appointment of a successor, which the Company expects to occur by the end of 2024.
February 28, 2024
·
4 min read
Business
Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024
Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced that it has rescheduled the release of the Company’s first quarter 2024 financial results to Monday, May 6, 2024.
April 18, 2024
·
1 min read
Business
Integra LifeSciences Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
Integra LifeSciences Holdings Corporation reported financial results for the fourth quarter and full year ended December 31, 2023.
February 28, 2024
·
24 min read
Pharm Country
Integra LifeSciences to Spotlight CereLink® Intracranial Pressure (ICP) Monitoring System at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting
Integra LifeSciences Holdings Corporation is pleased to announce that following a successful Q1 2024 U.S. relaunch of its CereLink® ICP Monitoring System, the innovative product will be featured at the upcoming AANS Annual Scientific Meeting from May 3 through 6, 2024, in Chicago, Illinois.
April 30, 2024
·
4 min read
1 of 29,710
Next
